Ricky W. Johnstone
Grattan Street
Melbourne, VIC 3000, Australia
Melbourne, VIC 3000, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 161 publications
Sensitivity of pancreatic adenocarcinoma cells to blockade of post-initiation CDK-dependent Pol II transcription cycle checkpoints.
Journal: Molecular cancer therapeutics
Published: December 18, 2025
An orally active dual CBP/p300 degrader targets core dependencies of multiple myeloma.
Journal: Cell reports
Published: November 13, 2025
Discovery and Characterization of VPRBP/DCAF1 Kinase Inhibitor Analogs as Microtubular Destabilizing Agents with Potent Antimyeloma Activity.
Journal: Molecular cancer therapeutics
Published: April 01, 2025
Stem-like memory and precursors of exhausted T cells share a common progenitor defined by ID3 expression.
Journal: Science immunology
Published: January 31, 2025
Principles of CRISPR-Cas13 mismatch intolerance enable selective silencing of point-mutated oncogenic RNA with single-base precision.
Journal: Science advances
Published: December 18, 2024
Dual Bcl-2/Bcl-xl inhibition via AZD0466 combines with immune checkpoint blockade to enhance anti-tumour activity.
Journal: Cell death & disease
Published: September 04, 2024
Inhibition of heme biosynthesis triggers cuproptosis in acute myeloid leukemia.
Journal: Cell
Published: June 17, 2024
CRISPR-Cas9 screening identifies an IRF1-SOCS1-mediated negative feedback loop that limits CXCL9 expression and antitumor immunity.
Journal: Cell reports
Published: February 07, 2024
Mapping the IMiD-dependent cereblon interactome using BioID-proximity labelling.
Journal: The FEBS journal
Published: December 03, 2023
PRMT1 acts as a suppressor of MHC-I and anti-tumor immunity.
Journal: Cell reports
Published: September 08, 2023
Last Updated: 09/26/2026